Paul Daruwala

Track

Insider profile

Currently holds a position at Cidara Therapeutics Inc

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 60% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Operating Officer Cidara Therapeutics Inc Jan. 1, 2017 -
Chief Commercial Officer Cidara Therapeutics Inc Dec. 1, 2014 - Jan. 1, 2017
Paul Daruwala's trades of Cidara Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-09-13 2022-09-12
S Sale
73,735 -45.2%
463.38
US$1,630,706 		73,735 -45.2% 463.38 US$1,630,706
2022-01-07 2022-01-05
S Sale
17,276 +8.1%
247.35
US$947,549 		17,276 +8.1% 247.35 US$947,549
2021-04-05 2021-04-01
S Sale
37,730 +29.8%
273.69
US$4,945,851 		37,730 +29.8% 273.69 US$4,945,851
2021-04-05 2021-01-05
S Sale
2,868 -5.5%
2.06
US$5,908 		2,868 -5.5% 2.06 US$5,908
2020-01-06 2020-01-03
S Sale
2,340 -4.2%
3.42
US$8,003 		2,340 -4.2% 3.42 US$8,003
2019-10-03 2019-10-02
S Sale
3,295 -5.6%
1.88
US$6,195 		3,295 -5.6% 1.88 US$6,195
2019-03-08 2019-03-07
S Sale
2,240 -4.3%
2.55
US$5,714 		2,240 -4.3% 2.55 US$5,714